Scinovex
article Open AccessTop 1% cited

Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis

Lara D. Veeken · 2010 · Vol. 49(10) · pp. 1852–1861

Abstract

Objectives. The osteochondral junction can be a source of pain in both RA and OA. Growth of blood vessels and nerves from the subchondral bone into articular cartilage may mediate the association between joint pathology and symptoms. We have investigated associations between angiogenesis, inflammation and neurovascular growth factor expression at the osteochondral junction in human arthritis. Methods. Osteochondral junctions from medial tibial plateaux of patients undergoing arthroplasty for RA (n = 10) or OA (n = 11), or from non-arthritic post-mortem controls (n = 11) were characterized by immunohistochemistry for CD34 and smooth muscle α-actin (blood vessels), CD68 (macrophages), CD3 (lymphocytes), proliferating cell nuclear antigen, vascular endothelial, platelet-derived and nerve growth factor (NGF). Results. Osteochondral angiogenesis was demonstrated as increased endothelial cell proliferation and vascular density in non-calcified articular cartilage, both in RA and OA. Osteochondral angiogenesis was associated with subchondral bone marrow replacement by fibrovascular tissue expressing VEGF, and with increased NGF expression within vascular channels. RA was characterized by greater lymphocyte infiltration and PDGF expression than OA, whereas chondrocyte expression of VEGF was a particular feature of OA. NGF was observed in vascular channels that contained calcitonin gene-related peptide-immunoreactive sensory nerve fibres. Conclusions. Osteochondral angiogenesis in RA and OA is associated with growth factor expression by cells within subchondral spaces, vascular channels and by chondrocytes. NGF expression and sensory nerve growth may link osteochondral angiogenesis to pain in arthritis.

Osteoarthritis Treatment and MechanismsRheumatoid Arthritis Research and TherapiesBone Metabolism and DiseasesMedicineOsteoarthritisRheumatoid arthritisAngiogenesisNerve growth factorSurgeryInternal medicinePathologyReceptor

MeSH terms

AdultAgedArthritis, RheumatoidCartilage, ArticularFemaleHumansKnee JointMaleMiddle AgedNeovascularization, PathologicOsteoarthritisStatistics as TopicSynovial MembraneNerve Growth Factor

Funding

  • AstraZeneca
Citations
421
FWCI
12.46
field-weighted impact
References
48
Percentile
99%
vs. same field & year
Citations per year
References
American Journal of Pathology
American Journal Of Pathology · 2015 · 4,956 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.